Browse > Article

Selective Antiproliferative and Apoptotic Effects of Quercetin in Normal Versus Tumorigenic Hepatic Cell Lines  

Jeon, Young-Mi (Lab. of Cell Biology in Department of Orthodontics and Institute of Oral Bioscience, Chonbuk National University)
Kim, Jong-Ghee (Lab. of Cell Biology in Department of Orthodontics and Institute of Oral Bioscience, Chonbuk National University)
Lee, Jeong-Chae (Lab. of Cell Biology in Department of Orthodontics and Institute of Oral Bioscience, Chonbuk National University)
Publication Information
Natural Product Sciences / v.10, no.3, 2004 , pp. 129-133 More about this Journal
Abstract
Quercetin is a dietary anticancer chemical that is capable of inducing apoptosis in tumor cells. However, little is known about its biological effect in nonmalignant hepatic cells. Using embryonic normal hepatic cell line (BNL CL.2) and its SV40-transformed tumorigenic cell line (BNL SV A.8), we evaluated the effects of quercetin on cell proliferation and apoptosis. As the results, our present study demonstrated that quercetin had a selective growth inhibition in normal versus tumorigenic hepatic cells such that BNL SV A.8 cells were very sensitive to the quercetin-mediated cytotoxicity. In particular, as evidenced by the increased number of positively stained cells in the TUNEL assay, the induction of characteristic nuclear DNA ladders, and the migration of many cells to sub-G1 phase in the BNL SV A.8 cells, quercetin treatment more sensitively induced apoptosis in BNL SV A8 cells than in BNL CL.2 cells. Collectively, our findings suggest that quercetin can be approached as a potential agent that is capable of inducing selective growth inhibition and apoptosis of hepatic cancer cells.
Keywords
Quercetin; Hepatocytes; Selective growth inhibition; Apoptosis;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Aligiannis, N., Mitaku, S., Mitrocotsa, D., and Leclerc, S., Flavonoids as cycline-dependent kinase inhibitors: Inhibition of cdc 25 phosphatase activity by flavonoids belonging to the quercetin and kaempferol series. Ptanta Med. 67, 468-470 (2001)   DOI   ScienceOn
2 Christou. L., Hatzimichael, E., Chaidos, A., Tsiara, S., and Bourantas, K.L., Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone. Eur. J. Haematol. 67, 51-53 (2001)   DOI   ScienceOn
3 Gao, Z., Huang, K., Yang, X., and Xu, H., Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim. Biophys. Acta 1472, 643-650 (1999)   DOI   ScienceOn
4 Miranda, C.L., Stevens, J.F., Helmrich, A., Henderson, M.C., Rodriguez, R.J., Yang, Y.H., Deinzer, M.L., Barnes, D.W., and Buhler, D.R., Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food chem. Toxicol. 37, 271-285 (1999)   DOI   ScienceOn
5 Pezutto, J.M., Plant-derived anticancer agents. Biochem. Pharmacol. 53, 121-133 (1997)
6 Formica, J.V. and Regelson, W., Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33, 1061-1080 (1995)   DOI   ScienceOn
7 Morel, I., Lescoat, G., Cogrel, P., Sergent, O., Pasdeloup, N., Brissot, P., Cillard, P., and Cillard, J., Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 45, 13-19 (1993)   DOI   ScienceOn
8 Mukherjee, A.K., Basu, S., Sarkar, N., and Ghosh, A.C., Advances in cancer therapy with plant based natural products. Curr. Med. Chem. 8, 1467-1486 (2001)   DOI   PUBMED   ScienceOn
9 Paschka, A.G., Butler, R., and Young, C.Y.F., Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett. 130, 1-7 (1998)   DOI   PUBMED   ScienceOn
10 Hollman, P.C. and Katan, M.B., Dietary Havonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 37, 937-942 (1999)   DOI   ScienceOn
11 Gamet-Payrastre, L., Manenti, S., Gratacap, M.P., Tulliez, J., Chap, H., and Payrastre, B., Flavonoids and the inhibition of PKC and PI3-kinase. Gen. Pharmacol. 32, 279-286 (1999)   DOI   ScienceOn
12 Gupta, S., Afaq, F., and Mukhtar, H., Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem. Biophys. Res. Commun. 287, 914-920 (2001)   DOI   ScienceOn
13 Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F.O., Natali, P.G., Brunetti, M., Aiello, F.B., and Piantelli, M., Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer 87, 595-600 (2000)   DOI   ScienceOn
14 Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G., and Hess, R.D., Flavonoids activate wild-type p53. Oncogene 13, 1605-1614 (1996)   PUBMED
15 Smets, L.A., Programmed cell death (apoptosis) and response to anti-cancer drugs. Anti-Cancer Drugs 5, 3-9 (1994)   PUBMED
16 Wong, W.S. and McLean, A.E., Effects of phenolic antioxidants and flavonoids on DNA synthesis in rat liver, spleen, and testis in vitro. Toxicology 139, 243-253 (1999)   DOI   ScienceOn
17 Yang, E.B., Zhang, K., Cheng, L.Y., and Mack, P., Butein, a specific protein tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 245, 435-438 (1998)   DOI   ScienceOn